Consistency: Deep research (falcon), review, and PN agree: ATP6V0D2 is the d2 isoform of the V0 d subunit (PMID:18752060), tissue-restricted (kidney intercalated cells, osteoclasts; PMID:15800125), with newer ccRCC evidence for late-autophagy lysosomal acidification + RAB7/HOPS fusion (PMID:39477683). Review adds GO:0007042 (NEW, NAS) and GO:0046610 (NEW, IC) — matching both PN projections. No contradictions.
PN story / NEW pressure: PN asserts lysosomal acidification + lysosomal V0-domain componency. For d2 these are genuinely new specificity beyond existing GO:0007035/GO:0033179, and PMID:39477683 gives gene-specific lysosomal-acidification support. Both terms verified real. The review flags appropriate caution (suggested_questions: should GO:0046610 propagate or await direct d2 lysosomal-complex evidence). ADD GO:0007042 + GO:0046610 — implemented, with honest IC/uncertainty framing.
Mapping strategy: Gene supports the leaf (true V0 d2 subunit). GO:0046610 narrows existing annotations; GO:0007042 narrows GO:0007035 vacuolar acidification — both defensible narrowings, not over-broad. Note d2's strongest isoform-specific biology is plasma-membrane proton secretion (kidney/osteoclast), so lysosomal projection is real-but-context-dependent; review correctly keeps it as a conservative addition, not the sole core.
Evidence alignment: PN cites generic V-ATPase/mTORC1 review titles; review adds the gene-specific PMID:18752060, PMID:15800125, PMID:39477683 absent from the PN reference list — a divergence where the review is better-sourced. No conflict.
Verdict: CONSISTENT — both NEW terms (verified real) appropriately added as conservative narrowings; PN projections align with review. No edits required.